https://www.cidrap.umn.edu/antimicrobial-stewardship/trial-clarifies-safety-risks-cefipime-piperacillin-tazobactam
0
0
10/16/23 at 7:02pm
Organization
Umn.edu
26 words
0
Comments
The trial results answer some questions about risk of acute kidney injury, neurotoxicity.
You are the first to view
Create an account
or login to join the discussion